Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Tuesday, September 29

2:55 PM - 3:05 PM ET

LBA 05 - NRG-HN009 Randomized Phase II/III Trial of RT + Cisplatin Q3 Weeks vs RT + Cisplatin Weekly for Patients with Locoregionally Advanced SCCHN: p16-Negative Phase II Toxicity Results
Speaker: Harari, Paul, MD, FASTRO - University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
3:05 PM - 3:15 PM ET

285 - Fractionated Stereotactic Radiotherapy for Limited Small Volume Brain Metastases: A Single-Center, Single Arm, Phase II Trial
Speaker: Ma, Yuchao, MD - Cancer Institute & Hospital Chinese Acedemy of Medical Sciences, Beijing, Beijing
3:05 PM - 3:15 PM ET

291 - Automated Identification and CTCAE Grading of Radiation-Induced Pneumonitis Using Large Language Models
Speaker: Li, Junyu, MD, RT - Jiang Xi Province Cancer Hospital, Nanchang
3:05 PM - 3:15 PM ET

297 - Planning, Delivery and Safety of Dose-Escalated Radiation in GRECO2: Secondary Analysis of a Large International Randomized Trial for Localized Pancreatic Cancer
Speaker: Kuehnle, Ryan, MD - JPS Health, Fort Worth, TX
3:05 PM - 3:15 PM ET

303 - Blockade of PD-1/PD-L1 Pathway Regulates Microglia Activation and Glycolipid Metabolism Via GPD1 to Ameliorate Radiation-Induced Brain Injury
Speaker: Zheng, Rong, MD, PhD - Fujian Medical University Union Hospital, Fuzhou, Fujian
3:05 PM - 3:15 PM ET

309 - Beyond DVH: Radiomics and Medical Foundation Models Improve Cardiac Event Prediction In Locally Advanced Non-Small Cell Lung Cancer
Speaker: Tie, Xin, PhD - University of Pennsylvania, Philadelphia, PA
3:05 PM - 3:15 PM ET

340 - Redundant Physician-Physicist Review as a Key Risk Barrier in HDR Brachytherapy for Patient Safety: Extension of a Complex Network Safety Model from TECDOC 1685
Speaker: Arevalo, Manuel - Universidad Nacional de Colombia, Bogota, Bogota
3:05 PM - 3:15 PM ET

LBA 06 - A Phase II Trial of Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma
Speaker: Raju-Salicki, Silpa, MD - Washington University in St. Louis, St. Louis, MO
3:15 PM - 3:25 PM ET

310 - Digital Twins of Clinical Trials In Head and Neck Squamous Cell Carcinoma: <em>In Silico </em>Models of Chemoradiation Resistance and Recurrence Patterns Predict Clinical Outcomes
Speaker: Stevens, Jack - Duke University, Durham, NC
3:15 PM - 3:25 PM ET

341 - Re-Engaging with Peer Review: Impact of a Restructured Contour/Plan Review Format in Radiation Oncology
Speaker: Starner, John, DO - Northwell Health, Lake Success, NY
3:15 PM - 3:25 PM ET

Discussant
Speaker: Gupta, Gaorav, MD, PhD - University of North Carolina, Chapel Hill, NC
3:15 PM - 3:25 PM ET

Discussant
Speaker: Chuong, Michael, MD - Miami Cancer Institute at Baptist Health South Florida, Miami, Florida